We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
Cap. Flow
-$1.11B
Cap. Flow %
-0.95%
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$89.2M
2
FLUT icon
Flutter Entertainment
FLUT
+$43.9M
3
OKTA icon
Okta
OKTA
+$32.1M
4
CHWY icon
Chewy
CHWY
+$31.8M
5
COIN icon
Coinbase
COIN
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 31.83%
2 Financials 13.86%
3 Consumer Discretionary 10.91%
4 Healthcare 9.41%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BILI icon
3301
Bilibili
BILI
$7.37B
$56K ﹤0.01%
2,612
-27
-1% -$497
ENOR icon
3302
iShares MSCI Norway ETF
ENOR
$101M
$56K ﹤0.01%
2,010
ICLR icon
3303
Icon
ICLR
$12.9B
$55.9K ﹤0.01%
384
-3,933
-91% -$558K
EDEN icon
3304
iShares MSCI Denmark ETF
EDEN
$206M
$55.5K ﹤0.01%
488
ACTU
3305
Actuate Therapeutics
ACTU
$23.2M
$55.5K ﹤0.01%
+9,082
New +$79.3K
HURA
3306
TuHURA Biosciences
HURA
$149M
$55.2K ﹤0.01%
+24,776
New +$83.7K
XNET
3307
Xunlei
XNET
$316M
$53.9K ﹤0.01%
13,302
+1,080
+9% +$5K
OPAL icon
3308
OPAL Fuels
OPAL
$67.1M
$53.6K ﹤0.01%
+22,165
New +$51.5K
MKTW icon
3309
MarketWise
MKTW
$55.5M
$53K ﹤0.01%
2,681
+545
+26% +$8.36K
INMB icon
3310
INmune Bio
INMB
$56.6M
$51.6K ﹤0.01%
22,336
+3,183
+17% +$23.4K
YMM icon
3311
Full Truck Alliance
YMM
$9.62B
$50.4K ﹤0.01%
4,267
-1,120
-21% -$13K
VRNA
3312
DELISTED
Verona Pharma
VRNA
$48.4K ﹤0.01%
512
-50
-9% -$3.7K
NXXT
3313
NextNRG Inc
NXXT
$46.9M
$48.4K ﹤0.01%
+17,482
New +$53.4K
ASAI
3314
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
$48.2K ﹤0.01%
4,666
+2,275
+95% +$23.5K
ARD
3315
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$47K ﹤0.01%
1,898
CMMB
3316
Chemomab Therapeutics
CMMB
$14.1M
$46.2K ﹤0.01%
9,969
+4,007
+67% +$19.8K
SVCO
3317
Silvaco Group
SVCO
$251M
$46.2K ﹤0.01%
9,781
+4,102
+72% +$19.4K
SOHU
3318
Sohu.com
SOHU
$369M
$46K ﹤0.01%
3,460
-54
-2% -$572
OS
3319
DELISTED
OneStream Inc
OS
$46K ﹤0.01%
1,625
HCM icon
3320
HUTCHMED
HCM
$2.13B
$45.6K ﹤0.01%
3,028
-272
-8% -$3.98K
SBC
3321
SBC Medical Group
SBC
$328M
$44.7K ﹤0.01%
+9,645
New +$38.1K
LK
3322
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
$44.2K ﹤0.01%
1,186
-381
-24% -$14.2K
IMMP
3323
Immutep
IMMP
$56.5M
$43.8K ﹤0.01%
26,717
-732
-3% -$1.27K
CDLR icon
3324
Cadeler
CDLR
$2.14B
$43K ﹤0.01%
2,164
-3
-0.1% -$61
ZTO icon
3325
ZTO Express
ZTO
$17.6B
$42.8K ﹤0.01%
2,413
-191
-7% -$3.46K

Similar funds

RhumbLine Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
  • RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
  • RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
  • RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
  • RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
  • RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.